Singapore Biobank Market Size & Outlook, 2023-2030
Singapore biobank market, 2018-2030 (US$M)
Related Markets
Singapore biobank market highlights
- The Singapore biobank market generated a revenue of USD 510.2 million in 2023 and is expected to reach USD 910.9 million by 2030.
- The Singapore market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
- In terms of segment, biobanking equipment was the largest revenue generating product in 2023.
- LIMS is the most lucrative product segment registering the fastest growth during the forecast period.
Biobank market data book summary
| Market revenue in 2023 | USD 510.2 million |
| Market revenue in 2030 | USD 910.9 million |
| Growth rate | 8.6% (CAGR from 2023 to 2030) |
| Largest segment | Biobanking equipment |
| Fastest growing segment | LIMS |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biobanking Equipment, Biobanking Consumables, LIMS |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH |
Other key industry trends
- In terms of revenue, Singapore accounted for 0.7% of the global biobank market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China biobank market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,169.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biobank Market Scope
Biobank Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Singapore biobank market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biobank market will help companies and investors design strategic landscapes.
Biobanking equipment was the largest segment with a revenue share of 76.91% in 2023. Horizon Databook has segmented the Singapore biobank market based on biobanking equipment, biobanking consumables, lims covering the revenue growth of each sub-segment from 2018 to 2030.
Singapore consists of several biobanking facilities, including NUH Tissue Repository Singapore, School of Public Health Tissue Repository (SPHTR) Singapore, and the Sing health Tissue Repository Singapore.
The country is expected to witness significant growth in the coming years due to the availability of an advanced infrastructure and skilled workforce. Moreover, the National Heart Centre Singapore (NHCS) Bio Bank was established for the collection and storage of patient samples and clinical data focused on cardiovascular disorders.
The biobank enables future use of the collected specimens for molecular, imaging, and other research studies based on cardiovascular disease. With rising investment in R&D activities in the country, the biobank market is expected to witness significant growth.
Reasons to subscribe to Singapore biobank market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Singapore biobank market databook
-
Our clientele includes a mix of biobank market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore biobank market , including forecasts for subscribers. This country databook contains high-level insights into Singapore biobank market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Singapore biobank market size, by product, 2018-2030 (US$M)
Singapore Biobank Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
